# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-25-068198
Filing Date
2025-05-09
Accepted
2025-05-09 17:02:17
Documents
96
Period of Report
2025-03-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | asth-20250331.htm iXBRL | 10-Q | 3851257
2 | EX-31.1 | asth-ex31_1.htm | EX-31.1 | 17767
3 | EX-31.2 | asth-ex31_2.htm | EX-31.2 | 17366
4 | EX-32 | asth-ex32.htm | EX-32 | 13759
5 | GRAPHIC | img124443625_0.jpg | GRAPHIC | 35722
| Complete submission text file | 0000950170-25-068198.txt |  | 17800481

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
6 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | asth-20250331.xsd | EX-101.SCH | 2111209
98 | EXTRACTED XBRL INSTANCE DOCUMENT | asth-20250331_htm.xml | XML | 4095256

Mailing Address 1668 S. GARFIELD AVENUE 2ND FLOOR ALHAMBRA CA 91801
Business Address 1668 S. GARFIELD AVENUE 2ND FLOOR ALHAMBRA CA 91801 (626) 282-0288
Astrana Health, Inc. (Filer) CIK: 0001083446 (see all company filings)

EIN.: 870042699 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37392 | Film No.: 25931464
SIC: 8742 Services-Management Consulting Services
(CF Office: 07 Trade & Services)